HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gérard Samuel Chetrite Selected Research

Enzymes

7/2005Control of sulfatase activity by nomegestrol acetate in normal and cancerous human breast tissues.
5/2004Dydrogesterone (Duphaston) and its 20-dihydro-derivative as selective estrogen enzyme modulators in human breast cancer cell lines. Effect on sulfatase and on 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity.
11/2003Effect of nomegestrol acetate on human estrogen sulfotransferase activity in the hormone-dependent MCF-7 and T-47D breast cancer cell lines.
2/2003Norelgestromin as selective estrogen enzyme modulator in human breast cancer cell lines. Effect on sulfatase activity in comparison to medroxyprogesterone acetate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gérard Samuel Chetrite Research Topics

Disease

4Breast Neoplasms (Breast Cancer)
07/2005 - 02/2003

Drug/Important Bio-Agent (IBA)

4EnzymesIBA
07/2005 - 02/2003
4Estradiol (Delestrogen)FDA LinkGeneric
07/2005 - 02/2003
3SulfatasesIBA
07/2005 - 02/2003
3Hormones (Hormone)IBA
07/2005 - 02/2003
3Estrogens (Estrogen)FDA Link
05/2004 - 02/2003
2Progestins (Progestagens)IBA
05/2004 - 11/2003
13 (or 17)-beta-hydroxysteroid dehydrogenaseIBA
07/2005
1DydrogesteroneFDA Link
05/2004
1SulfotransferasesIBA
11/2003
1estrone sulfotransferaseIBA
11/2003
1nomegestrol acetateIBA
11/2003
1Sulfates (Sulfates, Inorganic)IBA
11/2003
1AndrogensIBA
02/2003
1norelgestromin (LNGO)FDA Link
02/2003
1Hydroxysteroid DehydrogenasesIBA
02/2003
1estrone sulfataseIBA
02/2003
1norgestimateFDA LinkGeneric
02/2003
1estrone sulfate (Evex)FDA Link
02/2003
1Aromatase (CYP19)IBA
02/2003